Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer

• Status: Completed
• Trial end date: 2018-12-14
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the safety of Prasaprohyai 95% ethanolic extract at doses of 100 mg and 200 mg for for 6 weeks. (Clinical Trial phase I)

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Thammasat University
• Collaborator: Thai Traditional Medical Knowledge Fund

Criteria

Inclusion Criteria:

• 1) Age in range 20-60 years old.

• 2) Healthy, or don't have serious medical conditions such as congestive heart disease, liver and renal dysfunction, uncontrolled hypertension, severe asthma, tuberculosis, HIV in the previous month before being recruited in the study, using history taking and complete physical examination and laboratory result.

• 3) Do not taking a medicine constantly.

• 4) Female not pregnant or lactating (non menopause woman will have a pregnancy test. Time since first day of last menstruation 28-35 days).

• 5) Participant and agreement to follow the instructions for 8 weeks.

• 6) Not a participant in another study.

Exclusion Criteria:

• 1) Allergic reactions to Prasaprohyai medications.